Table 1.
Participant characteristics and fasting metabolic levels at baseline of each trial.
| Parameters | Mango (n = 24) | Control (n = 24) | P value |
|---|---|---|---|
| Age (years) | 21.0 ± 1.9 | 21.0 ± 1.9 | .91 |
| Height (in.) | 70.7 ± 0.6 | 70.6 ± 0.6 | .26 |
| Weight (kg) | 79.3 ± 3.0 | 78.3 ± 3.0 | .82 |
| BMI (kg/m2) | 24.6 ± 0.9 | 24.3 ± 0.9 | .81 |
| Waist circumference (in.) | 34.6 ± 0.9 | 34.4 ± 0.9 | .41 |
| Hip circumference (in.) | 37.2 ± 0.9 | 37.0 ± 0.7 | .50 |
| Systolic BP (mm Hg) | 122.8 ± 1.7 | 121.0 ± 2.4 | .26 |
| Diastolic BP (mm Hg) | 70.1 ± 1.5 | 69.6 ± 1.5 | .68 |
| Triglycerides (mg/dL) | 75.0 ± 11.5 | 77.1 ± 16.2 | .75 |
| Glucose (mg/dL) | 93.4 ± 1.8 | 96.0 ± 2.5 | .17 |
| NEFA (mEq/L) | 0.44 ± 0.05 | 0.42 ± 0.03 | .72 |
| HDL-C (mg/dL) | 58.2 ± 2.5 | 57.2 ± 2.3 | .56 |
| LDL-C (mg/dL) | 84.9 ± 4.0 | 86.9 ± 5.0 | .62 |
| Total-C (mg/dL) | 148.4 ± 6.2 | 159.3 ± 6.3 | .03 |
Data represent mean ± SEM.
Abbreviations: BMI, body mass index; BP, blood pressure; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; NEFA, nonesterified fatty acids; Total-C, total cholesterol.